Literature DB >> 23993226

Repositioning of a traumatically displaced globe with maxillary antrostomy: review of the literature and treatment recommendations.

Christopher J Haggerty1, Pat Roman.   

Abstract

Complete dislocation of the globe, inferiorly into the maxillary sinus, medially into the ethmoid sinus, or superiorly into the anterior cranial fossa, can occur with significant blunt facial trauma. The degree of injury to the globe, its adnexal structures, and the optic nerve is dependent on the extent of the dislocation. Complete traumatic subluxation of the globe into the maxillary sinus is associated with severe injury to the periocular structures and represents a challenging and unique reconstructive process rarely encountered in published studies. The present case report represents only the 15th reported case of complete orbital prolapse into the maxillary sinus. Controversy exists regarding the definitive treatment of traumatic globe dislocations, the risk of sympathetic ophthalmia (SO), the sequela of postenucleation socket syndrome, and prophylactic steroid treatment to decrease the incidence of SO and traumatic optic neuropathy.
Copyright © 2013 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23993226     DOI: 10.1016/j.joms.2013.07.002

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  3 in total

1.  Immediate Surgical Management of Traumatic Dislocation of the Eye Globe into the Maxillary Sinus: Report of a Rare Case and Literature Review.

Authors:  Samer Abduljabar Noman; Mostafa Ibrahim Shindy
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2016-06-24

2.  Traumatic Dislocation of the Globe into the Ethmoid Sinus

Authors:  Zafer Onaran; Gökçe Şimşek; Onur Konuk
Journal:  Turk J Ophthalmol       Date:  2021-10-26

3.  Traumatic prolapse of the globe into the anterior cranial fossa: a case report.

Authors:  Hui Liu; Shengli Hu; Wei Qin
Journal:  BMC Ophthalmol       Date:  2020-04-03       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.